Citizen Portal
Sign In

Get Full Government Meeting Transcripts, Videos, & Alerts Forever!

Get email alerts on the Patient Safety Allocation topic

No spam. Unsubscribe anytime.

OPTN officials say patient safety and allocation reforms (AOS, continuous distribution) are central to improving organ utilization

Organ Procurement and Transplantation Network (OPTN) · May 13, 2026
AI-Generated Content: All content on this page was generated by AI to highlight key points from the meeting. For complete details and context, we recommend watching the full video. so we can fix them.

Summary

OPTN and HHS officials told attendees that maintaining active safety committees (MPSC, DTAC) remains a priority during modernization, and that allocation tools such as allocation out of sequence (AOS) and continuous distribution will be advanced and iteratively refined to improve organ placement efficiency and equity.

OPTN leaders and patient representatives said the network will continue to prioritize patient safety as it modernizes technology and allocation policies, while advancing tools designed to increase organ utilization.

"When there are unexpected or untoward events...those are still being received and being processed," Dr. Raymond Lynch said, describing continued operations of safety review committees such as the MPSC and the Donor‑Derived Disease Transmission Advisory Committee (DTAC).

Officials also discussed policy work meant to improve placement efficiency, including Allocation Out of Sequence (AOS), finalized elements of NRP policy to be posted for public comment, and efforts to refine donation after circulatory death (DCD) rules. "AOS...striv[es] to improve placement efficiency and provide clearer pathways for expedited placement," Justin Wilkerson said.

Panelists cautioned that continuous distribution is an iterative improvement rather than a cure‑all. "Continuous distribution changes the playing field…it's an improvement upon the prior system," Bill Ryan said, adding that the approach will be monitored and adjusted as real‑world outcomes and data highlight unintended effects.

Speakers stressed the need for improved data quality and public dashboards to support monitoring and for sustained patient and donor family engagement in committees and public comments as policies are developed and implemented.